Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 231,789 | 122,977 | 102,833 | 107,810 | 112,204 |
| Cost of Goods | 12,298 | 2,989 | 450 | 395 | 382 |
| Gross Profit | 219,491 | 119,988 | 102,383 | 107,415 | 111,822 |
| Operating Expenses | 197,588 | 166,379 | 161,290 | 168,129 | 153,185 |
| Operating Income | 22,201 | -45,402 | -58,457 | -60,319 | -40,981 |
| Interest Expense | 11,160 | 9,455 | 4,061 | 4,047 | 3,719 |
| Other Income | 610 | 799 | 715 | 998 | 1,037 |
| Pre-tax Income | 11,651 | -54,058 | -61,803 | -63,368 | -43,663 |
| Income Tax | N/A | -615 | 562 | -863 | -216 |
| Net Income Continuous | 11,651 | -53,443 | -62,365 | -62,505 | -43,447 |
| Net Income | $11,651 | $-53,443 | $-62,365 | $-62,505 | $-43,447 |
| EPS Basic Total Ops | 0.12 | -0.59 | -0.68 | -0.69 | -0.49 |
| EPS Basic Continuous Ops | 0.12 | -0.58 | -0.69 | -0.69 | -0.49 |
| EPS Diluted Total Ops | 0.11 | -0.59 | -0.68 | -0.69 | -0.49 |
| EPS Diluted Continuous Ops | 0.11 | -0.58 | -0.69 | -0.69 | -0.49 |
| EBITDA(a) | $30,617 | $-37,476 | $-50,181 | $-52,417 | $-34,003 |